Clinical Trial Modernization-Optimizing the Supply of Decentralized Studies
Summary: The rise of decentralized trials (DCTs) in recent years illustrates a growing trend for more patient-centric solutions in clinical studies. As a result, the need for flexibility in supply has led to an increase in sponsors’ requests for more specialized services by clinical supply providers, including demand-led supply and direct-to-patient (DTP) distribution. What are some key supply considerations that sponsors need to keep in mind when planning a DCT? What should they look out for when choosing a supply partner for these types of studies?